BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25127184)

  • 21. When the non-sharing of therapeutic goals becomes the problem: The story of a consumer and his addiction to methadone.
    Faccio E; Aquili L; Anonymous ; Rocelli M
    J Psychiatr Ment Health Nurs; 2022 Apr; 29(2):174-180. PubMed ID: 34379854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.
    Sharp A; Carlson M; Howell V; Moore K; Schuman-Olivier Z
    J Subst Abuse Treat; 2021 Apr; 123():108247. PubMed ID: 33612190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.
    Cioe K; Biondi BE; Easly R; Simard A; Zheng X; Springer SA
    J Subst Abuse Treat; 2020 Dec; 119():108146. PubMed ID: 33138929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misalignment of Stakeholder Incentives in the Opioid Crisis.
    Boloori A; Arnetz BB; Viens F; Maiti T; Arnetz JE
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33081276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addiction Recovery: A Systematized Review.
    Inanlou M; Bahmani B; Farhoudian A; Rafiee F
    Iran J Psychiatry; 2020 Apr; 15(2):172-181. PubMed ID: 32426014
    [No Abstract]   [Full Text] [Related]  

  • 26. Worries About Discontinuing Buprenorphine Treatment: Scale Development and Clinical Correlates.
    Stein MD; Conti MT; Herman DS; Anderson BJ; Bailey GL; Noppen DV; Abrantes AM
    Am J Addict; 2019 Jul; 28(4):270-276. PubMed ID: 30993833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review.
    Jones JL; Mateus CF; Malcolm RJ; Brady KT; Back SE
    Front Psychiatry; 2018; 9():277. PubMed ID: 30140240
    [No Abstract]   [Full Text] [Related]  

  • 28. Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients.
    Kowalczyk WJ; Bertz JW; Moran LM; Phillips KA; Ghitza UE; Epstein DH; Preston KL
    J Addict Med; 2017; 11(6):454-460. PubMed ID: 28759482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stuck in limbo: illicit drug users' experiences with opioid maintenance treatment and the relation to recovery.
    Grønnestad TE; Sagvaag H
    Int J Qual Stud Health Well-being; 2016; 11():31992. PubMed ID: 27765141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.
    Notley C; Blyth A; Maskrey V; Craig J; Holland R
    Eur Addict Res; 2013; 19(6):287-98. PubMed ID: 23652159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
    Notley C; Blyth A; Maskrey V; Pinto H; Holland R
    Subst Abus; 2015; 36(2):232-9. PubMed ID: 25127184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
    Johnson B; Richert T
    Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.